These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31101124)

  • 1. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
    Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
    Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
    Xu Z; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk.
    Johansson A; Palli D; Masala G; Grioni S; Agnoli C; Tumino R; Giurdanella MC; Fasanelli F; Sacerdote C; Panico S; Mattiello A; Polidoro S; Jones ME; Schoemaker MJ; Orr N; Tomczyk K; Johnson N; Fletcher O; Perduca V; Baglietto L; Dugué PA; Southey MC; Giles GG; English DR; Milne RL; Severi G; Ambatipudi S; Cuenin C; Chajès V; Romieu I; Herceg Z; Swerdlow AJ; Vineis P; Flanagan JM
    Clin Epigenetics; 2019 Apr; 11(1):66. PubMed ID: 31039828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.
    Wilson LE; Harlid S; Xu Z; Sandler DP; Taylor JA
    Int J Obes (Lond); 2017 Jan; 41(1):194-199. PubMed ID: 27773939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
    Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
    Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
    Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenome-wide association study of breast cancer using prospectively collected sister study samples.
    Xu Z; Bolick SC; DeRoo LA; Weinberg CR; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2013 May; 105(10):694-700. PubMed ID: 23578854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies.
    Dugué PA; Bodelon C; Chung FF; Brewer HR; Ambatipudi S; Sampson JN; Cuenin C; Chajès V; Romieu I; Fiorito G; Sacerdote C; Krogh V; Panico S; Tumino R; Vineis P; Polidoro S; Baglietto L; English D; Severi G; Giles GG; Milne RL; Herceg Z; Garcia-Closas M; Flanagan JM; Southey MC
    Breast Cancer Res; 2022 Sep; 24(1):59. PubMed ID: 36068634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case-control Study.
    Chamberlain JA; Dugué PA; Bassett JK; Milne RL; Joo JE; Wong EM; Brinkman MT; Stuart GW; Boussioutas A; Southey MC; Giles GG; Mitchell H; English DR; Hodge AM
    Cancer Prev Res (Phila); 2021 Feb; 14(2):233-240. PubMed ID: 32958588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.
    Ambatipudi S; Horvath S; Perrier F; Cuenin C; Hernandez-Vargas H; Le Calvez-Kelm F; Durand G; Byrnes G; Ferrari P; Bouaoun L; Sklias A; Chajes V; Overvad K; Severi G; Baglietto L; Clavel-Chapelon F; Kaaks R; Barrdahl M; Boeing H; Trichopoulou A; Lagiou P; Naska A; Masala G; Agnoli C; Polidoro S; Tumino R; Panico S; Dollé M; Peeters PHM; Onland-Moret NC; Sandanger TM; Nøst TH; Weiderpass E; Quirós JR; Agudo A; Rodriguez-Barranco M; Huerta Castaño JM; Barricarte A; Fernández AM; Travis RC; Vineis P; Muller DC; Riboli E; Gunter M; Romieu I; Herceg Z
    Eur J Cancer; 2017 Apr; 75():299-307. PubMed ID: 28259012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort.
    Sturgeon SR; Sela DA; Browne EP; Einson J; Rani A; Halabi M; Kania T; Keezer A; Balasubramanian R; Ziegler RG; Schairer C; Kelsey KT; Arcaro KF
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1575-1581. PubMed ID: 34108140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
    Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
    BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    Hillary RF; McCartney DL; Smith HM; Bernabeu E; Gadd DA; Chybowska AD; Cheng Y; Murphy L; Wrobel N; Campbell A; Walker RM; Hayward C; Evans KL; McIntosh AM; Marioni RE
    PLoS Med; 2023 Jul; 20(7):e1004247. PubMed ID: 37410739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control meta-analysis of blood DNA methylation and autism spectrum disorder.
    Andrews SV; Sheppard B; Windham GC; Schieve LA; Schendel DE; Croen LA; Chopra P; Alisch RS; Newschaffer CJ; Warren ST; Feinberg AP; Fallin MD; Ladd-Acosta C
    Mol Autism; 2018; 9():40. PubMed ID: 29988321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol and DNA Methylation: An Epigenome-Wide Association Study in Blood and Normal Breast Tissue.
    Wilson LE; Xu Z; Harlid S; White AJ; Troester MA; Sandler DP; Taylor JA
    Am J Epidemiol; 2019 Jun; 188(6):1055-1065. PubMed ID: 30938765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
    Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
    Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.